Navigation Links
AlphaBio Centrix, LLC Announces a New Discovery for Programming Energetic Patches
Date:3/30/2012

LAS VEGAS, March 30, 2012 /PRNewswire/ -- AlphaBio Centrix, a Nevada-based biotech corporation, announced this week its development of a new bio-programming process – Infusion Technology. This is a term used in programming wearable TheraEX(TM) skin patches that can influence the human auric field, the energy field that surrounds all life forms.

When fully functional, this energy field is far reaching. In fact, in its basic form, it embodies seven major layers powered through seven major energy centers called Chakras.

"We are excited to share that we have discovered a way to use this auric field to influence specific bio-triggers which vibrate at a designated combination of frequencies," explains Richard Eaton, president, AlphaBio Centrix.

These frequencies communicate with, and enhance the body's natural energetic system. By wearing the TheraEX "Bio App" 24 hours a day for the duration of the protocol, the body is immersed in a corrective, informational and energetic exchange that promotes the balance of weak, disturbed and overactive energy.

AlphaBio Centrix uses a special substrate material for TheraEX ("Therapeutic Experience") that is sensitive to radio frequencies and is bonded to a non-latex woven medical pad manufactured by 3M Company. It's been formulated with an adhesive made for different types of skin conditions. This substrate material is then transformed by Infusion Technology, adding digital information onto the material.

These Bio Apps are an ideal alternative health care solution, and according to its recent research studies, mounting stress problems are causing an overwhelming effect on people's health and emotional problems. Stress factors include: today's uncertain work environment; and increasing workloads which may result in work-related injuries and health problems.

For more information on TheraEX(TM) visit: http://alphabiocentrix.com/products/thera-ex-apps-for-healing-and-frequency-medicine/ .

AlphaBio Centrix is also developing other products that are uniquely positioned to sell to homeopathic doctors and other health care professionals.

For more information on the company, visit: www.alphabiocentrix.com .

- Image 72dpi: Send2Press.com/mediaboom/12-0402-theraex_72dpi.jpg

This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R). http://www.Send2Press.com


'/>"/>
SOURCE AlphaBio Centrix, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
2. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
3. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
4. Anesiva Announces Second Quarter 2008 Financial Results and Update
5. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
6. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
7. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
8. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
9. ThirdBiotech Announces Kemeta as Newest Sponsor
10. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
11. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... 2017 , ... Total Orthopedics and Sports Medicine ( http://www.totalorthosportsmed.com ... operation took place on Wednesday, January 11, 2017 at Long Island Jewish, Valley ... discectomy and fusion on a 42 year old female who was in a ...
(Date:1/18/2017)... FL (PRWEB) , ... January 18, 2017 , ... ... weakness and paralysis, today announced that it has submitted a 510(k) to the ... bikes that utilize MYOLYN’s patent-pending functional electrical stimulation (FES) technology. , The ...
(Date:1/18/2017)... ... January 18, 2017 , ... BidMed, LLC, announced it will ... genetic testing lab equipment from two different leading institutes. This highly specialized laboratory equipment ... the United States. This 1-day online auction will take place on BidMed’s website ...
(Date:1/18/2017)... 18, 2017 Shareholder rights law firm Johnson ... the board members of CoLucid Pharmaceuticals, Inc. (NASDAQ: ... with the proposed sale of the Company to Eli ... develops small molecules for the acute treatment of migraines. ... had signed a definitive merger agreement with Eli Lilly. ...
Breaking Biology Technology:
(Date:1/3/2017)... LAS VEGAS , Jan. 3, 2017 ... announced the introduction of Onitor Track, an innovative biometric ... and men, showcasing this month at the 2017 Consumer ... . In the U.S., the World ... affect more than two-thirds of adults who are overweight ...
(Date:12/19/2016)... y TORONTO , 19 de diciembre de 2016 ... Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado ... tipos de tumor en 2017, con múltiples sitios previstos a lo ... ... objetivo en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica ...
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, Inc. ... genomics technology company, announced today that on December 13, ... Department of The Nasdaq Stock Market LLC which acknowledged ... price of WaferGen,s common stock had been at $1.00 ... has regained compliance with Listing Rule 5550(a)(2) of the ...
Breaking Biology News(10 mins):